{"id":1417,"date":"2021-10-26T12:01:02","date_gmt":"2021-10-26T12:01:02","guid":{"rendered":""},"modified":"2021-12-03T09:51:32","modified_gmt":"2021-12-03T09:51:32","slug":"page-1981","status":"publish","type":"post","link":"https:\/\/copolad.eu\/es\/page-1981\/","title":{"rendered":"European drug prevention quality standards"},"content":{"rendered":"<div id=\"articleHeader\"><strong style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen-Sans, Ubuntu, Cantarell, 'Helvetica Neue', sans-serif;\">EMCDDA<\/strong><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen-Sans, Ubuntu, Cantarell, 'Helvetica Neue', sans-serif;\">. European Monitoring Centre for Drugs and Drug Addiction<\/span><\/div>\n<section>\n<div>\n<p>This Manual is a joint production by the EMCDDA and the Prevention Standards Partnership, and presents and describes basic and expert level quality standards for drug prevention. The standards cover all aspects of drug prevention work, including needs and resource assessment, programme planning, intervention design, resource management, implementation, monitoring and evaluation, dissemination, sustainability, stakeholder involvement, staff development, and ethics. Considerations regarding the standards\u2019 real-life implementation are provided, acknowledging differences in professional culture, policy, and the structure of prevention delivery within Europe.<\/p>\n<p>Additional resources can be found on the\u00a0<a href=\"http:\/\/prevention-standards.eu\/\" target=\"_blank\" rel=\"noopener\">European Drug Prevention Quality Standards website [external website]<\/a><\/p>\n<\/div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<p>La Comisi\u00f3n Europea est\u00e1 preparando una tercera fase de este programa, por lo que COPOLAD volver\u00e1 a principios de 2021.<\/p>\n<p><a title=\"Acceder en ingl\u00e9s\" href=\"https:\/\/copolad.eu\/wp-content\/uploads\/attachments\/TD3111250ENC_318193.pdf\" target=\"_blank\" rel=\"noopener\">Acceder en ingl\u00e9s<\/a><\/p>\n<div><a href=\"http:\/\/copolad.eu\/es\/newsletter\/copolad-atlas-final?view_lang=es\" target=\"_blank\" rel=\"noopener\">Carta final COPOLAD II<br \/>\n<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>EMCDDA. European Monitoring Centre for Drugs and Drug Addiction This Manual is a joint production by the EMCDDA and the Prevention Standards Partnership, and presents and describes basic and expert level quality standards for drug prevention. The standards cover all aspects of drug prevention work, including needs and resource assessment, programme planning, intervention design, resource [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":1418,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","video":"","gallery":"","source_name":"","source_url":"","via_name":"","via_url":"","override_template":"0","override":[{"template":"1","single_blog_custom":"","parallax":"1","fullscreen":"1","layout":"right-sidebar","sidebar":"default-sidebar","second_sidebar":"default-sidebar","sticky_sidebar":"1","share_position":"top","share_float_style":"share-monocrhome","show_share_counter":"1","show_view_counter":"1","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_author_image":"1","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"0","post_reading_time_wpm":"300","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","number_popup_post":"1","show_author_box":"0","show_post_related":"0","show_inline_post_related":"0"}],"override_image_size":"0","image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post":"0","trending_post_position":"meta","trending_post_label":"Trending","sponsored_post":"0","sponsored_post_label":"Sponsored by","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo_enable":"0","sponsored_post_logo":"","sponsored_post_desc":""},"jnews_primary_category":{"id":"29"},"jnews_social_meta":{"fb_title":"","fb_description":"","fb_image":"","twitter_title":"","twitter_description":"","twitter_image":""},"jnews_override_counter":{"override_view_counter":"0","view_counter_number":"0","override_share_counter":"0","share_counter_number":"0","override_like_counter":"0","like_counter_number":"0","override_dislike_counter":"0","dislike_counter_number":"0"},"jnews_post_split":{"enable_post_split":"0","post_split":[{"template":"1","tag":"h2","numbering":"asc","mode":"normal","first":"0","enable_toc":"0","toc_type":"normal"}]},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1417","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar"],"acf":[],"_links":{"self":[{"href":"https:\/\/copolad.eu\/es\/wp-json\/wp\/v2\/posts\/1417"}],"collection":[{"href":"https:\/\/copolad.eu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/copolad.eu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/copolad.eu\/es\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/copolad.eu\/es\/wp-json\/wp\/v2\/comments?post=1417"}],"version-history":[{"count":0,"href":"https:\/\/copolad.eu\/es\/wp-json\/wp\/v2\/posts\/1417\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/copolad.eu\/es\/wp-json\/wp\/v2\/media\/1418"}],"wp:attachment":[{"href":"https:\/\/copolad.eu\/es\/wp-json\/wp\/v2\/media?parent=1417"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/copolad.eu\/es\/wp-json\/wp\/v2\/categories?post=1417"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/copolad.eu\/es\/wp-json\/wp\/v2\/tags?post=1417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}